Identification of a Novel Pathogenic Variant in the NAGLU Gene in a Child with Neurodevelopmental Delay

Lucia Pia Bruno^{1

2}, Francesca Fava^{1

2

3}, Margherita Baldassarri^{1

2}, Virginia M Salvati⁴, Valeria Scandurra⁵, Roberto Canitano⁵, Floriana Valentino^{1

2}, Gabriella Doddato^{1

2}, Rossella Tita³, Annarita Giliberti^{1

2}, Alessandra Renieri^{1

2

3}, Francesca Ariani^{6

7

8}

Affiliations

¹ Medical Genetics Unit, University of Siena, Policlinico Le Scotte, Viale Bracci, 2, 53100, Siena, Italy.
² Med Biotech Hub and Competence Center, Department of Medical Biotechnologies, University of Siena, Siena, Italy.
³ Genetica Medica, Azienda Ospedaliero-Universitaria Senese, Siena, Italy.
⁴ UOSD Pediatria Cava de' Tirreni- AOU S. Giovanni di Dio e Ruggi d'Aragona, Salerno, Italy.
⁵ Division of Child and Adolescent Neuropsychiatry, University Hospital of Siena, Siena, Italy.
⁶ Medical Genetics Unit, University of Siena, Policlinico Le Scotte, Viale Bracci, 2, 53100, Siena, Italy. francesca.ariani@unisi.it.
⁷ Med Biotech Hub and Competence Center, Department of Medical Biotechnologies, University of Siena, Siena, Italy. francesca.ariani@unisi.it.
⁸ Genetica Medica, Azienda Ospedaliero-Universitaria Senese, Siena, Italy. francesca.ariani@unisi.it.

Lucia Pia Bruno et al. J Autism Dev Disord. 2022 Oct.

. 2022 Oct;52(10):4605-4607.

doi: 10.1007/s10803-021-05332-x. Epub 2021 Oct 28.

¹ Medical Genetics Unit, University of Siena, Policlinico Le Scotte, Viale Bracci, 2, 53100, Siena, Italy.
² Med Biotech Hub and Competence Center, Department of Medical Biotechnologies, University of Siena, Siena, Italy.
³ Genetica Medica, Azienda Ospedaliero-Universitaria Senese, Siena, Italy.
⁴ UOSD Pediatria Cava de' Tirreni- AOU S. Giovanni di Dio e Ruggi d'Aragona, Salerno, Italy.
⁵ Division of Child and Adolescent Neuropsychiatry, University Hospital of Siena, Siena, Italy.
⁶ Medical Genetics Unit, University of Siena, Policlinico Le Scotte, Viale Bracci, 2, 53100, Siena, Italy. francesca.ariani@unisi.it.
⁷ Med Biotech Hub and Competence Center, Department of Medical Biotechnologies, University of Siena, Siena, Italy. francesca.ariani@unisi.it.
⁸ Genetica Medica, Azienda Ospedaliero-Universitaria Senese, Siena, Italy. francesca.ariani@unisi.it.

No abstract available

References

1. Benetó, N., Vilageliu, L., Grinberg, D., & Canals, I. (2020). Sanfilippo syndrome: Molecular basis, disease models and therapeutic approaches. International Journal of Molecular Sciences, 21(21), 7819. - DOI
1. Kaczor-Kamińska, M., Stalińska, K., Kamiński, K., Pisarek, A., Maziarz, U., Feldman, A., & Wróbel, M. (2020). Murine cellular model of mucopolysaccharidosis, type IIIB (MPS IIIB) - A preliminary study with particular emphasis on the non-oxidative l-cysteine metabolism. Biochimie, 174, 84–94. - DOI
1. Khan, S. A., Peracha, H., Ballhausen, D., Wiesbauer, A., Rohrbach, M., Gautschi, M., Mason, R. W., Giugliani, R., Suzuki, Y., Orii, K. E., Orii, T., & Tomatsu, S. (2017). Epidemiology of mucopolysaccharidoses. Molecular Genetics and Metabolism, 121(3), 227–240. - DOI
1. Lidia, G., Pierzynowska, K., Piotrowska, E., & Wegrzyn, G. (2018). How close are we to therapies for Sanfilippo disease? Metabolic Brain Disease, 33, 1–10. - DOI
1. Lin, H. Y., Lo, Y. T., Wang, T. J., et al. (2019). Normalization of glycosaminoglycan-derived disaccharides detected by tandem mass spectrometry assay for the diagnosis of mucopolysaccharidosis. Science and Reports, 9, 10755. - DOI